 |
News
Today the public testing of the MetaTrader 5 client terminal starts. All of you now can participate in it. If you want to become the testing participant, just download the terminal and test it. You can send your bug reports and suggestions by email or publish them in this topic.
For the testing period, the client terminal is offered with the English interface. If you have any difficulties, please refer to the built in Help, which is also in English.
You can download MetaTrader 5 Client Terminal by the following link: http://files.metaquotes.net/metaquotes/mt5/mt5setup.exe (7Mb)We thank you in advance for your contribution in testing the MetaTrader 5 terminal!
Plans for MetaTrader 5 Testing
- The platform testing will take about 5-6 months.
- This will be a step-by-step testing. New possibilities will be added at each step. During the first testing stage that starts today, the client terminal will work only with Forex. Further we will add CFD, Futures, equities and options.
- The current terminal version is offered without a strategy tester. It will be included at next steps.
- From November, 2009, we open the testing of back-office components of the platform in brokerage companies.
We do our best to offer you the maximally stable product, that's why the testing process has a multi-step structure. We want to thoroughly check everything before we offer the platform to our clients.
Best regards,
MetaQuotes Software Corp.
The 9th of September is an important date in the history of the MetaTrader 5 trading platform. We are in the final stage of the platform development - it is the starting day of the closed beta-testing of the MetaTrader 5 terminal.
The new client terminal has been sent to some members of the MQL4.community for testing. They will help us find errors that unfortunately always accompany the developments of new products. Being created from scratch, MetaTrader 5 is not an exception.
We have conducted the diverse testing of the MetaTrader 5 terminal in our testing department. However, we decided to conduct this closed testing, so that finally the general public is offered the reliable, trouble-free terminal. The closed testing will be followed by the public beta-testing; and all persons interested can participate in it. Follow the news!
April 1-3 2009 the MetaTrader 5 Workshop was conducted in Kazan. Technical specialists of some of our clients were invited to this event. The main purpose of the meeting was the discussion of the MetaTrader 5 platform that is currently being developed.
Our company was represented by Renat Fatkhullin and Alexander Saidullin, as well as heads of all international offices of MetaQuotes Software Corp. We invited representatives of brokerage companies from all over the world and special guests.
The following issues were the subject of discussions during the meeting:
- Architecture of the MetaTrader 5 platform.
- Further development of the platform.
- Using MetaTrader 5 in stock markets, as well as for trading futures and options.
- Back office, integration with TeamWox and other software.
The platform and its presentation were shown at the MetaTrader 5 Workshop.
According to the results of the meeting held, the following decisions have been made:
- In summer 2009 we are planning to start the public beta-testing of the MetaTrader 5 client terminal and the new language for programming trading strategies MQL5.
- In autumn the beta-testing of MetaTrader 5 back-office components will be started.
- The main efforts of MetaTrader 5 developers will be concentrated on the maximal flexibility of the platform. "Our platform must be able to easily integrate with the largest possible number of other software, stocks and liquidity providers. This is one of the most important tasks we are going to work on", - Alexander Saidullin, the chief developer of MetaTrader 5, concluded.
We would like to thank all those who came to the Workshop and participated in the discussion of the new platform. We are sure that now we will be able to make MetaTrader 5 maximally convenient for the business of our clients.